Page last updated: 2024-08-16

sarpogrelate and nitroglycerin

sarpogrelate has been researched along with nitroglycerin in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujita, M; Hanada, H; Kinugawa, T; Lee, JD; Miyamoto, S; Nakajima, H1
Chayama, K; Goto, C; Higashi, Y; Miyazaki, M; Orihashi, K; Sanada, H; Sueda, T; Yoshizumi, M1

Trials

1 trial(s) available for sarpogrelate and nitroglycerin

ArticleYear
Sarpogrelate hydrochloride, a selective 5-HT2A antagonist, improves vascular function in patients with peripheral arterial disease.
    Journal of cardiovascular pharmacology, 2007, Volume: 49, Issue:4

    Topics: Aged; Aged, 80 and over; Analysis of Variance; Arterial Occlusive Diseases; Biomarkers; Endothelium, Vascular; Female; Follow-Up Studies; Forearm; Humans; Hyperemia; Leg; Male; Nitroglycerin; Peripheral Vascular Diseases; Regional Blood Flow; Research Design; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Succinates; Time Factors; Treatment Outcome; Vasodilator Agents

2007

Other Studies

1 other study(ies) available for sarpogrelate and nitroglycerin

ArticleYear
Effectiveness of a novel serotonin blocker, sarpogrelate, for patients with angina pectoris.
    American heart journal, 2002, Volume: 144, Issue:2

    Topics: Aged; Angina Pectoris; Chronic Disease; Collateral Circulation; Coronary Angiography; Drug Therapy, Combination; Exercise; Exercise Test; Female; Humans; Male; Middle Aged; Nitroglycerin; Serotonin Antagonists; Succinates; Treatment Outcome

2002